US 12415866
Monoclonal antibody inhibitor of Factor XIIa
granted A61KA61K2039/505A61P
Quick answer
US patent 12415866 (Monoclonal antibody inhibitor of Factor XIIa) held by Takeda Pharmaceutical Company Limited expires Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Takeda Pharmaceutical Company Limited
- Grant date
- Tue Sep 16 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 11 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 13
- CPC classes
- A61K, A61K2039/505, A61P, A61P11/00, A61P27/02